AHC
BMY icon

Adell Harriman & Carpenter’s Bristol-Myers Squibb BMY Stock Holding History

Adell Harriman & Carpenter’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,198
Closed -$241K – 171
2025
Q2 		$241K Buy
5,198
+23
+0.4% +$1.13K 0.02% 161
2025
Q1 		$316K Hold
5,175
– – 0.02% 148
2024
Q4 		$293K Hold
5,175
– – 0.02% 150
2024
Q3 		$268K Sell
5,175
-235
-4% -$11K 0.02% 151
2024
Q2 		$225K Sell
5,410
-458
-8% -$20.5K 0.02% 154
2024
Q1 		$318K Sell
5,868
-2
-0% -$102 0.03% 144
2023
Q4 		$301K Buy
5,870
+625
+12% +$32.8K 0.03% 144
2023
Q3 		$304K Sell
5,245
-393
-7% -$24.1K 0.03% 144
2023
Q2 		$363K Sell
5,638
-82
-1% -$5.5K 0.04% 137
2023
Q1 		$396K Buy
+5,720
New +$403K 0.04% 134
2022
Q2 		– Sell
-2,840
Closed -$207K – 142
2022
Q1 		$207K Buy
+2,840
New +$191K 0.02% 168
2021
Q4 		– Sell
-4,424
Closed -$262K – 179
2021
Q3 		$262K Buy
4,424
+450
+11% +$29.6K 0.03% 163
2021
Q2 		$266K Hold
3,974
– – 0.03% 159
2021
Q1 		$251K Sell
3,974
-161
-4% -$10K 0.03% 149
2020
Q4 		$257K Sell
4,135
-120
-3% -$7.38K 0.03% 140
2020
Q3 		$257K Sell
4,255
-875
-17% -$52.7K 0.04% 135
2020
Q2 		$302K Sell
5,130
-300
-6% -$17.9K 0.05% 114
2020
Q1 		$303K Sell
5,430
-320
-6% -$19.6K 0.06% 112
2019
Q4 		$369K Buy
+5,750
New +$329K 0.06% 116

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Adell Harriman & Carpenter's BMY Position: Q3 2025 in Review

Adell Harriman & Carpenter sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 5,198 shares — an estimated $241K sold.

Adell Harriman & Carpenter first reported a position in BMY in Q4 2019 and held it in 19 quarters. The position peaked at $396K in Q1 2023. 2,275 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Adell Harriman & Carpenter reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 5,198 Bristol-Myers Squibb shares in Q3 2025, an estimated $241K.
  • Adell Harriman & Carpenter first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 19 quarters.
  • Adell Harriman & Carpenter's Bristol-Myers Squibb position peaked at $396K in Q1 2023.
  • 2,275 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Adell Harriman & Carpenter's 13F filing for Q3 2025, filed 4 Nov 2025.